$33MVenture, 12 March 2026
Owkin spun out its diagnostics unit as independent company Waiv with $33M to scale AI precision testing.
- Amount
- $33M
- Stage
- Venture
- Announced
- 12 March 2026
- Lead
- OTB Ventures
- Other investors
- Alpha Intelligence Capital, Serena Data Ventures, Karista, SistaFund
- Use of funds
- Owkin spun out its diagnostics unit as independent company Waiv with $33M to scale AI precision testing.
- Checked
- Announced by the company
- Sources
- Owkin spinout Waiv raises $33M for AI precision oncology testing businesswire.com
Owkin spinout Waiv raises $33M for AI precision oncology testing pulse2.com